Global Life Science Software Market – Industry Trends and Forecast to 2030

Análisis y tamaño del mercado de software para ciencias biológicas

El software de ciencias biológicas incluye una colección de herramientas de estandarización de flujos de trabajo y gestión de documentos para servir a las industrias biofarmacéutica , de tecnología médica, de medicamentos genéricos y de atención clínica. Las empresas pueden utilizar este software para registrar, almacenar y retener de forma segura datos en forma de fotos y textos. Este software convierte los datos a un formato electrónico, lo que permite a los profesionales de la salud acceder rápidamente a los datos y adquirir información útil. La identificación y validación de fármacos, la gestión de laboratorios, la administración de ensayos clínicos y la invención de dispositivos médicos son algunas de las aplicaciones de software de ciencias biológicas.

Data Bridge Market Research analiza que se espera que el mercado mundial de software de ciencias biológicas, que se valoró en 16.320 millones de dólares en 2022, alcance los 44.720 millones de dólares en 2030, con un crecimiento anual compuesto del 12,9 % durante el período de pronóstico de 2023 a 2030. El informe de mercado elaborado por el equipo de Data Bridge Market Research incluye un análisis profundo de expertos, epidemiología de los pacientes, análisis de la cartera de productos, análisis de precios y marco regulatorio. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado elaborados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de los pacientes, análisis de la cartera de productos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de software para ciencias biológicas

Definición de mercado

Las ciencias biológicas se ocupan del estudio científico de los organismos, entre los que se incluyen microorganismos, seres humanos y animales. La biología, la anatomía, las ciencias de la salud, las ciencias médicas y la medicina son solo algunas de las muchas disciplinas de estudio de las ciencias biológicas. El software de ciencias biológicas ayuda a ofrecer soluciones integrales y completas para el negocio de las ciencias biológicas, que incluyen calidad del producto, normativas, velocidad de comercialización, rentabilidad y muchas otras, en el creciente entorno sanitario actual.

Dinámica del mercado mundial de software para ciencias biológicas

Conductores

• Aumento del uso de análisis para aplicaciones de marketing y ventas

La creciente presión para reducir los costos de la atención médica, la mayor aceptación de las soluciones analíticas en los ensayos clínicos y la creciente demanda de una mayor estandarización de los datos son factores que impulsan la industria del software de ciencias biológicas. En el período previsto de 2023 a 2030, los avances tecnológicos y la adopción de tácticas de adquisiciones y fusiones entre las distintas ciencias biológicas generarán más oportunidades para el mercado del software de ciencias biológicas.

• Avances tecnológicos continuos

La disponibilidad de big data en la industria de las ciencias biológicas, la creciente adopción de soluciones analíticas en hospitales y clínicas y en la industria farmacéutica para ventas y marketing, y la creciente necesidad de mejorar la atención al paciente son algunos de los principales factores que impulsan el crecimiento del mercado de software para las ciencias biológicas. Además, factores como el aumento de las enfermedades crónicas, la creciente presión para recortar el gasto sanitario y un enfoque creciente en la medicina basada en el valor contribuyen a la fuerte expansión del mercado.

• Adopción de herramientas analíticas avanzadas para el descubrimiento de nuevos fármacos

Life sciences sector globally has gained considerably from the developments in analytical solutions. Emerging technologies such as AI have a big potential to improve and speed drug discovery. Also, AI driven life science analytics tools aid in novel medication research and development, drug repurposing, boosting pharmaceutical productivity, and others. Also, AI technology decreases the human workload, eliminates human error and achieves targets in the short time-period. Hence, key companies in the market are coming up with effective strategic alliances to acquire prominent place in the market, which may also positively affect the worldwide market

Opportunities

• Growing Volume of Healthcare Data, Including Electronic Health Records (EHRs), Wearable Device Data, and Real-World Evidence

The growing volume of healthcare data, including electronic health records (EHRs), wearable device data, and real-world evidence, creates opportunities for software solutions that can extract valuable insights for researchers, clinicians, and pharmaceutical companies

• Advancements in Precision Medicine

The increasing focus on precision medicine, which tailors healthcare and drug treatments to individual patients based on their genetic makeup and health history, presents a significant opportunity for life science software. Advanced software can help in the analysis of vast genomic and clinical data, enabling more personalized treatment strategies

Restraints/Challenges

• Stringent Regulatory Environment

The life science industry is subject to strict regulatory requirements, which can vary significantly from region to region. Meeting these compliance standards is both time-consuming and costly. Overcoming this restraint requires continuous investment in regulatory expertise and software development to ensure compliance, which can be challenging for smaller software providers

• Data Privacy and Security Concerns

The handling of sensitive patient data and personal health information requires robust data security measures. Data breaches and privacy concerns can significantly damage trust and reputation. Overcoming these concerns necessitates ongoing investments in cybersecurity and adherence to evolving data protection regulations.

This global life science software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global life science software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Recent Development

• In May 2021, IQVIA acquired Myriad Genetics' rival division. This division, dubbed Myriad RBM, is expected to be integrated into IQVIA's Q2 Solutions. Myriad RBM provides contract research services to the pharmaceutical industry, including screening diseased and non-diseased clinical samples against the company's menu of biomarkers
• In June 2021, Microsoft introduced Kathy VanEnkevort as the new General Manager for the Health and Life Sciences Industry team

Global Life Science Software Market Scope

The global life science software market  is segmented on the basis of type, application, component and solution. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Predictive
• Descriptive
• Prescriptive

Application

• Marketing
• Compliance
• R&D
• Pharmacovigilance
• SCM

Component

• Software
• Service

Solution

• Cloud-based
• On-Premises

Global Life Science Software Market Regional Analysis/Insights

The global life science software market is analyzed and market size insights and trends are provided by type, application, component, and solution as referenced above.

The countries covered in the global life science software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the market due to the improved adoption rate of advanced technologies and a large number of investments.

Asia-Pacific is expected to grow during the forecast period of 2023 to 2030 due to increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global life science software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for life science software Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global life science software market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Global Life Science Software Market Share Analysis

The global life science software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to global life science software market.

Some of the major players operating in the global life science software market are:

• MEDICAL Information Technology Inc. (U.S.)
• SAP (Germany)
• CPSI (U.S.)
• Meta (U.S.)
• Elinext (U.S.)
• EPIC Systems Corporation (U.S.)
• INFOR (U.S.)
• Cognizant (U.S.)
• Oracle (U.S.)
• Jag products LLC (U.S.)
• Allscripts Healthcare LLC (U.S.)
• Optum Inc. (U.S.)
• Cerner Corporation (U.S.)
• Change Healthcare (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• athenahealth (U.S.)
• eClinicalWorks (U.S.)

SKU-55092